| 产品名称： | Cryptococcus gattii (Vanbreuseghem et Takashio) Kwon-Chung et Boekhout |
|---|---|
| 商品货号： | TS190404 |
| Deposited As： | Cryptococcus neoformans var. gattii |
| Strain Designations： | CBS 11529 |
| Alternate State： | Filobasidiella bacillispora Kwon-Chung, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Antigenic Properties： | serotype B
Ref  Bottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | EJ Bottone |
| Isolation： | Human pulmonary lesion, New York |
| References： | Bottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 Bottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Cryptococcus gattii (Vanbreuseghem et Takashio) Kwon-Chung et Boekhout |
|---|---|
| 商品货号： | TS190404 |
| Deposited As： | Cryptococcus neoformans var. gattii |
| Strain Designations： | CBS 11529 |
| Alternate State： | Filobasidiella bacillispora Kwon-Chung, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Antigenic Properties： | serotype B
RefBottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | EJ Bottone |
| Isolation： | Human pulmonary lesion, New York |
| References： | Bottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 Bottone EJ, et al. Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J. Clin. Microbiol. 23: 186-188, 1986. PubMed: 3517042 |
